ArticleBlood advances2023

Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.

Mohammad Azhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.